Feed INBX
IN
Inhibrx Biosciences Inc.
INBX · NASDAQ
$85.92 -0.21% (-$0.18)
1M -6.33%
Market Cap $1.3B
P/E Ratio -
Div. Yield -
ROE 269.56%
Bulios Fair Price
$171.35
99.4% upside
Current Price
$85.92
Undervalued Fair Value Overvalued
Valuation
0 /100
Expensive P/B 160.81x
P/S 988.73x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 48.36%
Rev. growth 15.98%
FCF growth N/A
Profitability
0 /100
Weak Net margin 0.00%
Op. margin 0.00%
FCF margin 0.00%
Quality
0 /100
Poor ROE 0.00%
ROA 0.00%
Asset turnover 0.01x
Debt
70 /100
Low Current ratio 3.68x
Int. coverage 16.72x
Net debt/EBITDA 0.19x
Stability
1 /100
Unstable Rev. volatility 350.17%
EPS volatility 1,415.79%
Profitable years 0
Ask StockBot about INBX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark Lappe
Employees
109
Headquarters
La Jolla
Upcoming events
12 AUG
Earnings
Upcoming earnings report